| Balance sheet (USD) | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 | FY 2019 ended Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 3.34M | 3.87M | 6.96M | 20.48M | 18.70M | 26.89M |
| Total assets | 10.68M | 4.64M | 8.28M | 22.54M | 20.18M | 33.03M |
From Addex Therapeutics Ltd.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.